Search
Use the filters to narrow by type of content
Looking for a Publication? Search the bibliography for: services pricing database cfm
… Medicare to directly negotiate - for the first time - pricing for certain drugs. The Maximum Fair Price (MFP) … competition. How the Center for Medicare & Medicaid Services (CMS) negotiations might affect research and … new on the horizon for Round 2 drug negotiations. Related Services Market Access and Outcomes Strategy Staff Members …
… Assess Long-Term Treatment Effects with Pooled Database Analysis Share on: November 27, 2023 For drug and … studies, both internal and external, into a pooled database for analysis. A well-designed pooled data analysis … and to improve the quality of care for patients. Related Services Biostatistics …
… the scoping stage Long-term cost-effectiveness: A dynamic pricing scenario for small molecule and biological products … To reflect future Centers for Medicare & Medicaid Services price negotiation under the Inflation Reduction Act, … loss of exclusivity or Centers for Medicare & Medicaid Services negotiation is expected among all active comparators …
… are already being felt. Government negotiation of drug pricing within the Medicare system is becoming a reality. The … requirements and procedures for HTAs, market access, and pricing across Europe. Drug developers have been operating …
… entities are tasked with ensuring that their products and services are accessible and beneficial to all people, … efforts, thereby ensuring that biopharma products and services produce more mutually reinforcing benefits, … better health outcomes. Research can lead the way. Related Services Health Economics Staff Members Mark Price …
… clearance, or licensure of the product or new use Product pricing information Patient utilization projections (e.g., … on incidence and prevalence) Product-related programs or services Factual presentations of results from studies, … models likely not possible AMCP Format 4.1 (2020) Related Services Market Access and Outcomes Strategy Staff Members …
New Real-World Evidence of Effective Treatment in Non-Small-Cell Lung Cancer with Capmatinib Share on: February 27, 2023 Non-small cell lung cancer (NSCLC) is an aggressive disease, with poor prognosis and a high likelihood of brain metastases. Overall …
… FDA approval of the product or of the new use Product pricing information Patient utilization projections such as … on incidence and prevalence Product-related programs or services (e.g., patient support programs) Presentations of … payers, contact one of our market access experts. Related Services Market Access and Outcomes Strategy Staff Members …
… RWE and RWD capabilities, click here . Related Services Health Economics Health Economics: Database Studies Pharmacoepidemiology and Risk Management …
… doi: 10.1182/blood-2019-122841. Related Services Health Economics: Database Studies Staff Members Ravi Goyal Saurabh Nagar Keith …